25 Aug Health Data News Roundup: Healthcare AI Legal Considerations; MA Member Satisfaction Declines; and Trump’s Health IT Journey
Welcome to the Health Data Weekly News Roundup from IMAT Solutions. As the power of data continues to grow in the healthcare arena, today’s care organizations need to be on the forefront of all news and trends to help ensure that their data analytics efforts deliver accountable and informed care. Each week, we will provide you with the actionable news you need to meet these goals.
Trump’s HHS Just Embarked on a Thorny Journey in Health IT, Industry Experts Say
As the Trump administration tries to make Medicare more modern through the use of digital health apps, it faces a horde of unresolved policy issues that could present challenges to its stated goal to “stop theoretical debates and start delivering real results,” according to Fierce Healthcare.
Legal Considerations Critical as AI in Healthcare Burgeons
As artificial intelligence’s (AI) use in healthcare ramps up, stakeholders need to be cognizant that while not all US legislation has kept up, existing laws are often still applicable, a legal expert recent told Medical Device Network magazine.
Medicare Advantage Member Satisfaction Declines as Trust Wanes
Policy changes and uncertainty in the Medicare Advantage landscape have contributed to a decline in trust and member satisfaction — down 29 points from last year — according to new data from J.D. Power that was highlighted by xtelligent Healthcare Payers.
TEFCA Participants Liable for Federal Information Blocking Rule
Last month, the Assistant Secretary for Technology Policy released a federal FAQ warning that TEFCA participants who interfere with Qualified Health Information Network choice risk violating the federal information blocking rule, according to xtelligent Health IT and EHR.
Elevance Loses Medicare Advantage Star Ratings Challenge
A Texas federal judge dismissed Elevance Health’s lawsuit challenging its 2025 Medicare Advantage star ratings, ruling that the company “has not shown any evidence that CMS acted arbitrarily or capriciously,” according to Becker’s Payer Issues.
Sorry, the comment form is closed at this time.